Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
Seminars in Oncology
|
August 17, 2010
Cancer screening trials: nuts and bolts
Philip C Prorok, Pamela M Marcus
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
January 24, 2014
Screening for Prostate Cancer with Prostate-Specific Antigen: What's the Evidence?
Pamela M Marcus, Barnett S Kramer
Lung Cancer (Amsterdam, Netherlands)
|
July 1, 2008
Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: an example from the Mayo Lung Project
V Paul Doria-Rose, Pamela M Marcus
JNCI Cancer Spectrum
|
July 31, 2019
Lung Cancer Mortality in the Lung Screening Study Feasibility Trial
Maryam Doroudi, Paul F Pinsky, Pamela M Marcus
Lung Cancer (Amsterdam, Netherlands)
|
January 14, 2021
Do competing causes of mortality contribute to overdiagnosis in lung cancer screening?
Danielle D Durham, Jennifer M Croswell, Pamela M Marcus
American Journal of Preventive Medicine
|
July 14, 2015
Targeted Cancer Screening in Average-Risk Individuals
Pamela M Marcus, Andrew N Freedman, Muin J Khoury
Contemporary Clinical Trials
|
May 8, 2012
Tracking and tracing of participants in two large cancer screening trials
Pamela M Marcus, Jeffery Childs, Betsy Gahagan, et al.
American Journal of Preventive Medicine
|
October 21, 2017
Patterns of Prostate-Specific Antigen Test Use in the U.S., 2005-2015
Zahava Berkowitz, Jun Li, Thomas B Richards, et al.
Reviews on Recent Clinical Trials
|
August 5, 2015
Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center
Lisa H Gren, Lois E Lamerato, Patrick Wright, et al.
Journal of Medical Screening
|
June 2, 2012
Recruitment methods employed in the National Lung Screening Trial
Pamela M Marcus, Suzanne Lenz, Donna Sammons, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
Seminars in Oncology
|
August 17, 2010
Cancer screening trials: nuts and bolts
Philip C Prorok, Pamela M Marcus
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
January 24, 2014
Screening for Prostate Cancer with Prostate-Specific Antigen: What's the Evidence?
Pamela M Marcus, Barnett S Kramer
Lung Cancer (Amsterdam, Netherlands)
|
July 1, 2008
Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: an example from the Mayo Lung Project
V Paul Doria-Rose, Pamela M Marcus
JNCI Cancer Spectrum
|
July 31, 2019
Lung Cancer Mortality in the Lung Screening Study Feasibility Trial
Maryam Doroudi, Paul F Pinsky, Pamela M Marcus
Lung Cancer (Amsterdam, Netherlands)
|
January 14, 2021
Do competing causes of mortality contribute to overdiagnosis in lung cancer screening?
Danielle D Durham, Jennifer M Croswell, Pamela M Marcus
American Journal of Preventive Medicine
|
July 14, 2015
Targeted Cancer Screening in Average-Risk Individuals
Pamela M Marcus, Andrew N Freedman, Muin J Khoury
Contemporary Clinical Trials
|
May 8, 2012
Tracking and tracing of participants in two large cancer screening trials
Pamela M Marcus, Jeffery Childs, Betsy Gahagan, et al.
American Journal of Preventive Medicine
|
October 21, 2017
Patterns of Prostate-Specific Antigen Test Use in the U.S., 2005-2015
Zahava Berkowitz, Jun Li, Thomas B Richards, et al.
Reviews on Recent Clinical Trials
|
August 5, 2015
Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center
Lisa H Gren, Lois E Lamerato, Patrick Wright, et al.
Journal of Medical Screening
|
June 2, 2012
Recruitment methods employed in the National Lung Screening Trial
Pamela M Marcus, Suzanne Lenz, Donna Sammons, et al.
Page
of 6